KBC Groupe (OTC:KBCSY) Stock, Quote.Headers.trade-ideas

KBC Group

KBC was formed in 1998 by the merger of Belgian commercial bank Kredietbank, cooperative farmers bank CERA Bank, and cooperative insurer ABB Verzekering. KBC offers banking, insurance, and investment products. Belgium and the Czech Republic account for the most of KBC's profits, while the bank has smaller operations in Hungary, Slovakia, and Bulgaria.

News

Intraday Update

Markets

Movers

Trading Ideas

AAXN

ACEL

ADBE

ADCOF

AEHR

AIQUY

AJRD

ALSWF

AMAT

AMRC

AMXEF

ANSS

APEMY

ARCAY

ARCVF

ARES

ARNC

ASMLF

ASTE

AVLR

AVXL

BAESY

BCLI

BESIY

BFAM

BILI

BILL

BRLXF

BTAI

BWXT

BXMT

CALX

CCYC

CDNS

CNSWF

CRMT

CTAS

CYTK

DAVA

DOCU

DOOO

DRUNF

ENTG

EQIX

ESPR

EXLS

EXPGF

EXPO

FAST

FCPT

FLIR

FZRO

GASE

GLIBA

GNRC

GRRB

HENC

HIMX

Hannover Ruckversicherungs Registered shares 

HVRRY

ICAD

Stocks That Hit 52-Week Highs On Thursday

ACGL

ACLS

ACRE

AGNC

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALLT

ALLVF

ALNY

ALPMY

ALSK

AMED

APAM

AQUA

ARMZF

ASHTF

ASHTY

ASML

ASND

ASPU

BAYZF

BCPC

CBRE

CBSH

CCMP

CCOI

CCXI

CGEN

CIFAF

CLBK

CLPBY

CSLLY

CTVEF

CWEN

CWEN-A

DKILY

DQJCY

DSDVY

DSNKY

ENPH

EONGY

EPRT

Eaton Vance Tax-Advantaged Global Dividend

FBHS

FELE

Flaherty Crumrine/Claymore Preferred Securities

Movers & Shakers

General

AAWW

ACOR

AGGG

AMCX

AMKAF

ARLP

ATRO

ATTO

AVLIF

BACHF

BBBY

BHKLY

BIREF

BJCHF

BMRN

BMWYY

BLUE PRISM GROUP PLC ORD by Blue Prism Group PLC

BPRMF

BRTX

CAKE

CARB

CATC

CDEV

CEQXF

CFWFF

CGNSF

CHMJF

COMM

CPCAY

CRTPF

CTPCY

CTTAY

CVET

CWYCY

CYCC

DDAIF

DLAKY

DMLRY

DNKEY

DSEEY

DSFGY

DSITF

EBIX

ELIO

ESVIF

ETRN

FOCS

FORR

FUPBY

GBHL

GFSZF

GFSZY

GHSI

GIII

GNFT

GVHIB

HDSN

HNRG

HSNGY

HUSKF

IBKR

IDCBY

IDSA

IFRX

ILUS

INAP

INPX

JBFCF

JBFCY

Stocks That Hit 52-Week Lows On Thursday

KBC Groupe NV

KBC (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KBCSY#OTC">KBCSY</a>) is set to give its latest quarterly earnings report on Thursday, 2023-02-09. Here's what investors need to know before the announcement.
Analysts estimate that KBC will report an earnings per share (EPS) of $1.01. 
KBC bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.16, which was followed by a 2.03% increase in the share price the next day.
Here's a look at KBC's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
<th>Q4 2021</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.76</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.92</td>
<td>1.02</td>
<td>0.6</td>
<td>0.89</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.03%</td>
<td>0.48%</td>
<td>0.67%</td>
<td>-2.44%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of KBC were trading at $36.645 as of February 07. Over the last 52-week period, shares are down 18.51%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/KBCSY/earnings">To track all earnings releases for KBC visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

KBCSY

KBC's Earnings: A Preview

&nbsp;
<h2>Upgrades</h2>
<ul>
<li>Barrington Research upgraded the previous rating for Dentsply Sirona Inc (NASDAQ:<a class="ticker" href="/stock/XRAY#NASDAQ">XRAY</a>) from Market Perform to Outperform. Dentsply Sirona earned $0.87 in the fourth quarter, compared to $0.73 in the year-ago quarter. The stock has a 52-week-high of $60.78 and a 52-week-low of $31.57. At the end of the last trading period, Dentsply Sirona closed at $59.71.</li>
<li>BTIG upgraded the previous rating for TrueCar Inc (NASDAQ:<a class="ticker" href="/stock/TRUE#NASDAQ">TRUE</a>) from Neutral to Buy. For the fourth quarter, TrueCar had an EPS of $0.01, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $6.47 and a 52-week-low of $1.98. TrueCar closed at $5.18 at the end of the last trading period.</li>
<li>For Zoom Video Communications Inc (NASDAQ:<a class="ticker" href="/stock/ZM#NASDAQ">ZM</a>), Piper Sandler upgraded the previous rating of Neutral to Overweight. For the fourth quarter, Zoom Video Communications had an EPS of $1.22, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $588.84 and a 52-week-low of $97.37. Zoom Video Communications closed at $409.66 at the end of the last trading period.</li>
<li>CIBC upgraded the previous rating for Bank of Nova Scotia (NYSE:<a class="ticker" href="/stock/BNS#NYSE">BNS</a>) from Neutral to Outperformer. In the first quarter, Bank of Nova Scotia showed an EPS of $1.44, compared to $1.41 from the year-ago quarter. The stock has a 52-week-high of $61.35 and a 52-week-low of $31.94. At the end of the last trading period, Bank of Nova Scotia closed at $59.74.</li>
<li>According to BMO Capital, the prior rating for Extra Space Storage Inc (NYSE:<a class="ticker" href="/stock/EXR#NYSE">EXR</a>) was changed from Market Perform to Outperform. In the fourth quarter, Extra Space Storage showed an EPS of $1.48, compared to $1.27 from the year-ago quarter. The stock has a 52-week-high of $131.59 and a 52-week-low of $72.70. At the end of the last trading period, Extra Space Storage closed at $123.67.</li>
<li>Exane BNP Paribas upgraded the previous rating for Tenaris SA (NYSE:<a class="ticker" href="/stock/TS#NYSE">TS</a>) from Underperform to Neutral. Tenaris earned $0.18 in the fourth quarter, compared to $0.26 in the year-ago quarter. The current stock performance of Tenaris shows a 52-week-high of $21.97 and a 52-week-low of $8.86. Moreover, at the end of the last trading period, the closing price was at $21.55.</li>
<li>For Satsuma Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="/stock/STSA#NASDAQ">STSA</a>), Credit Suisse upgraded the previous rating of Underperform to Neutral. Satsuma Pharmaceuticals earned $0.69 in the third quarter, compared to $2.26 in the year-ago quarter. The stock has a 52-week-high of $36.10 and a 52-week-low of $3.50. At the end of the last trading period, Satsuma Pharmaceuticals closed at $6.51.</li>
<li>For Repay Holdings Corp (NASDAQ:<a class="ticker" href="/stock/RPAY#NASDAQ">RPAY</a>), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. Repay Holdings earned $0.17 in the fourth quarter, compared to $0.20 in the year-ago quarter. The current stock performance of Repay Holdings shows a 52-week-high of $28.42 and a 52-week-low of $10.69. Moreover, at the end of the last trading period, the closing price was at $22.63.</li>
<li>According to KeyBanc, the prior rating for Akamai Technologies Inc (NASDAQ:<a class="ticker" href="/stock/AKAM#NASDAQ">AKAM</a>) was changed from Sector Weight to Overweight. In the fourth quarter, Akamai Technologies showed an EPS of $1.33, compared to $1.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $124.91 and a 52-week-low of $75.18. Akamai Technologies closed at $95.94 at the end of the last trading period.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
&nbsp;
<h2>Downgrades</h2>
<ul>
<li>According to Wedbush, the prior rating for Skyline Champion Corp (NYSE:<a class="ticker" href="/stock/SKY#NYSE">SKY</a>) was changed from Outperform to Neutral. In the third quarter, Skyline Champion showed an EPS of $0.38, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $47.57 and a 52-week-low of $10.82. At the end of the last trading period, Skyline Champion closed at $46.86.</li>
<li>For ADT Inc (NYSE:<a class="ticker" href="/stock/ADT#NYSE">ADT</a>), Barclays downgraded the previous rating of Equal-Weight to Underweight. ADT earned $0.12 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of ADT shows a 52-week-high of $17.21 and a 52-week-low of $3.40. Moreover, at the end of the last trading period, the closing price was at $7.73.</li>
<li>For Inseego Corp (NASDAQ:<a class="ticker" href="/stock/INSG#NASDAQ">INSG</a>), Stifel downgraded the previous rating of Buy to Hold. In the fourth quarter, Inseego showed an EPS of $0.07, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $21.93 and a 52-week-low of $3.91. At the end of the last trading period, Inseego closed at $15.03.</li>
<li>According to Raymond James, the prior rating for Switch Inc (NYSE:<a class="ticker" href="/stock/SWCH#NYSE">SWCH</a>) was changed from Strong Buy to Outperform. In the fourth quarter, Switch showed an EPS of $0.06, compared to $0.04 from the year-ago quarter. The current stock performance of Switch shows a 52-week-high of $19.99 and a 52-week-low of $10.30. Moreover, at the end of the last trading period, the closing price was at $17.69.</li>
<li>According to Needham, the prior rating for Applied Optoelectronics Inc (NASDAQ:<a class="ticker" href="/stock/AAOI#NASDAQ">AAOI</a>) was changed from Buy to Hold. Applied Optoelectronics earned $0.20 in the fourth quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.57 and a 52-week-low of $5.00. Applied Optoelectronics closed at $9.02 at the end of the last trading period.</li>
<li>For Athenex Inc (NASDAQ:<a class="ticker" href="/stock/ATNX#NASDAQ">ATNX</a>), Truist Securities downgraded the previous rating of Buy to Hold. In the fourth quarter, Athenex showed an EPS of $0.53, compared to $0.28 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.24 and a 52-week-low of $5.24. Athenex closed at $5.46 at the end of the last trading period.</li>
<li>According to Jefferies, the prior rating for FibroGen Inc (NASDAQ:<a class="ticker" href="/stock/FGEN#NASDAQ">FGEN</a>) was changed from Buy to Hold. For the fourth quarter, FibroGen had an EPS of $0.64, compared to year-ago quarter EPS of $1.12. At the moment, the stock has a 52-week-high of $57.21 and a 52-week-low of $22.65. FibroGen closed at $50.53 at the end of the last trading period.</li>
<li>For Viatris Inc (NASDAQ:<a class="ticker" href="/stock/VTRS#NASDAQ">VTRS</a>), JP Morgan downgraded the previous rating of Overweight to Neutral. The current stock performance of Viatris shows a 52-week-high of $18.86 and a 52-week-low of $14.56. Moreover, at the end of the last trading period, the closing price was at $14.72.</li>
<li>JP Morgan downgraded the previous rating for Athenex Inc (NASDAQ:<a class="ticker" href="/stock/ATNX#NASDAQ">ATNX</a>) from Overweight to Neutral. For the fourth quarter, Athenex had an EPS of $0.53, compared to year-ago quarter EPS of $0.28. The current stock performance of Athenex shows a 52-week-high of $15.24 and a 52-week-low of $5.24. Moreover, at the end of the last trading period, the closing price was at $5.46.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h2>Initiations</h2>
<ul>
<li>For Lucira Health Inc (NASDAQ:<a class="ticker" href="/stock/LHDX#NASDAQ">LHDX</a>), William Blair initiated coverage, by setting the current rating at Outperform. The stock has a 52-week-high of $37.98 and a 52-week-low of $18.27. At the end of the last trading period, Lucira Health closed at $19.39.</li>
<li>Stifel initiated coverage on Angion Biomedica Corp (NASDAQ:<a class="ticker" href="/stock/ANGN#NASDAQ">ANGN</a>) with a Buy rating. The price target for Angion Biomedica is set to $40.00. The stock has a 52-week-high of $26.30 and a 52-week-low of $16.00. At the end of the last trading period, Angion Biomedica closed at $19.92.</li>
<li>Benchmark initiated coverage on Clene Inc (NASDAQ:<a class="ticker" href="/stock/CLNN#NASDAQ">CLNN</a>) with a Buy rating. The price target for Clene is set to $25.00. The stock has a 52-week-high of $16.50 and a 52-week-low of $6.23. At the end of the last trading period, Clene closed at $13.58.</li>
<li>Guggenheim initiated coverage on Bolt Biotherapeutics Inc (NASDAQ:<a class="ticker" href="/stock/BOLT#NASDAQ">BOLT</a>) with a Buy rating. The price target for Bolt Biotherapeutics is set to $42.00. The stock has a 52-week-high of $35.88 and a 52-week-low of $22.63. At the end of the last trading period, Bolt Biotherapeutics closed at $30.00.</li>
<li>Morgan Stanley initiated coverage on MP Materials Corp (NYSE:<a class="ticker" href="/stock/MP#NYSE">MP</a>) with an Overweight rating. The price target for MP Materials is set to $57.00. At the moment, the stock has a 52-week-high of $49.43 and a 52-week-low of $15.45. MP Materials closed at $46.37 at the end of the last trading period.</li>
<li>With an Overweight rating, Morgan Stanley initiated coverage on Bolt Biotherapeutics Inc (NASDAQ:<a class="ticker" href="/stock/BOLT#NASDAQ">BOLT</a>). The price target seems to have been set at $45.00 for Bolt Biotherapeutics. The stock has a 52-week-high of $35.88 and a 52-week-low of $22.63. At the end of the last trading period, Bolt Biotherapeutics closed at $30.00.</li>
<li>With an Outperform rating, SVB Leerink initiated coverage on Pharvaris NV (NASDAQ:<a class="ticker" href="/stock/PHVS#NASDAQ">PHVS</a>). The price target seems to have been set at $50.00 for Pharvaris. The current stock performance of Pharvaris shows a 52-week-high of $42.86 and a 52-week-low of $23.06. Moreover, at the end of the last trading period, the closing price was at $39.23.</li>
<li>With a Neutral rating, Goldman Sachs initiated coverage on Immunocore Holdings PLC (NASDAQ:<a class="ticker" href="/stock/IMCR#NASDAQ">IMCR</a>). The price target seems to have been set at $40.00 for Immunocore Holdings. The current stock performance of Immunocore Holdings shows a 52-week-high of $61.99 and a 52-week-low of $39.02. Moreover, at the end of the last trading period, the closing price was at $49.05.</li>
<li>With an Overweight rating, Piper Sandler initiated coverage on AVITA Medical Inc (NASDAQ:<a class="ticker" href="/stock/RCEL#NASDAQ">RCEL</a>). The price target seems to have been set at $27.00 for AVITA Medical. AVITA Medical earned $0.26 in the second quarter. The current stock performance of AVITA Medical shows a 52-week-high of $30.78 and a 52-week-low of $4.00. Moreover, at the end of the last trading period, the closing price was at $21.49.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Comments

KBC Groupe

KBC Groupe (KBCSY) Forecast

KBC Groupe (OTC:KBCSY) Stock, Quote.Headers.trade-ideas